Genmab A/S Files Form 6-K for March 2025
Ticker: GNMSF · Form: 6-K · Filed: Mar 6, 2025 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Mar 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, registration-statement
TL;DR
Genmab filed a 6-K for March 2025, incorporating it into existing S-8 filings.
AI Summary
Genmab A/S filed a Form 6-K on March 6, 2025, to report information for the month of March 2025. This filing is incorporated by reference into several of Genmab's S-8 registration statements, including File Nos. 333-232693, 333-253519, 333-262970, 333-277273, and 333-284876.
Why It Matters
This filing serves as an update for investors and indicates ongoing reporting requirements for Genmab A/S with the SEC.
Risk Assessment
Risk Level: low — This is a routine filing that incorporates previous information and does not introduce new material risks.
Key Players & Entities
- Genmab A/S (company) — Registrant
- 333-232693 (dollar_amount) — S-8 Registration Statement File Number
- 333-253519 (dollar_amount) — S-8 Registration Statement File Number
- 333-262970 (dollar_amount) — S-8 Registration Statement File Number
- 333-277273 (dollar_amount) — S-8 Registration Statement File Number
- 333-284876 (dollar_amount) — S-8 Registration Statement File Number
FAQ
What type of SEC filing is this document?
This document is a Form 6-K, which is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
What period does this Form 6-K report cover?
This report is for the month of March 2025.
What is the filing date of this report?
The filing date is March 6, 2025.
How is this filing related to Genmab A/S's registration statements?
This Form 6-K is deemed to be incorporated by reference into Genmab A/S's registration statements on Form S-8 (File Nos. 333-232693, 333-253519, 333-262970, 333-277273 and 333-284876).
What is the principal executive office address of Genmab A/S?
The principal executive offices are located at Carl Jacobsens Vej 30, 2500 Valby, Denmark.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 6, 2025 regarding GENMAB A/S (GNMSF).